Free audit in 48 hours

Life Sciences · GEO Investor Assessment

Due diligence on you now starts in a chat.

Analysis and monitoring of what AI engines tell analysts, funds and counterparties about soundness, governance and risks — before the first meeting.

Request the free 48-hour audit

Example sample: 480 questions to five engines, one dot per answer
ChatGPTGeminiPerplexityClaudeCopilot
  • 52%Correct
  • 20%Dated facts
  • 11%Unattended sources
  • 17%Doesn't name you
ChatGPT · the circled answer in the sample, annotated with its sources

Question“Is Meridian Pharma a good investment target?”

AI answerMeridian Pharma operates in a competitive market. The 2020 controversy over the price of a medicine is cited as a reputational risk.1 Some dated sources describe the pipeline as weak.2 [No mention of recent studies, partnerships or updated pipeline data.]3

  1. DatedThe 2020 controversy is cited in the risk analyses of two financial websites.financial websites · 2021
  2. DatedThe pipeline is described with 2020 data: three studies started later do not appear.clinical trial registries · 2020
  3. MissingThe updated pipeline and partnerships are in an investor presentation PDF.investor relations PDF, not cited

Illustrative example with a fictitious company. In the assessment every note links to the source URL.

The GEO Investor Assessment for life sciences is the service that analyses what generative AI engines tell analysts, funds and counterparties about the pipeline, governance and risks of a company in the industry — before the data room — and how to correct the sources that form that first judgement.

What has changed

Whoever evaluates you no longer starts from the data room. They start from an AI answer.

“Is [Company] worth investing in?”

“What are the risks of [Company]?”

“How is the governance of [Company]?”

×2ChatGPT weekly users doubled in a year: from ~400 to ~800–900 million
8%click-through when an AI answer appears (vs 15% without): your press releases are not opened
60%of searches already end without a single click: the summary is enough

Sources: OpenAI / press 2025 · Pew Research 2025 · SparkToro 2024 — US / cross-industry data, to be read as a trend.

The problem

Analysts and counterparties ask the AI before opening the data room.

And the judgement forms before the first meeting.

The sources that matter

Where the answer comes from, for this audience

Clinical registries and institutional sources

ClinicalTrials.gov, EMA, AIFA: AI cites them for pipeline and study status.

Financial and trade press

Articles on pipeline, partnerships and controversies: the heaviest sources in questions about risks.

IR releases and data in HTML

AI reads them if extractable; presentations and PDFs are not picked up.

Analyses and investor forums

Dated opinions on the pipeline weigh on Perplexity and ChatGPT in "is it worth investing" questions.

The solution

How the GEO Assessment works

1

We ask the AI engines

We put the real questions of your audience to several models (ChatGPT, Gemini, Perplexity, Claude, Copilot), by market and role.

2

We find the sources

We identify the actual articles and pages that form that perception, with verified URLs.

3

We give you the plan, and carry it out

Score, gaps and concrete actions per touchpoint. Your team executes them, or we do: content, sources, presence. Then we measure again.

What you receive: GEO Score A–F · Visual SWOT · Source map · Reputational risks · Action plan · Competitor comparison. One branded report, exportable to PDF, generated by the proprietary ReputAction platform. And with monitoring, the same snapshot repeated over time: you see how far your positioning has moved.

The method in detail →

A case, anonymised

Listed life sciences company, pipeline renewed after 2022

"What are the risks" described the pipeline as weak on the basis of 2021 sources; recent studies and partnerships never appeared. The plan made pipeline data extractable in HTML, aligned the public clinical registries, updated Wikipedia with sources and secured trade coverage on the partnerships. At 90 days the answers cite the recent studies in three cases out of four; the 2021 assessment appears with its date.

All results →

Inside the platform

Continuous oversight before roadshows and negotiations

Monthly score and alerts: if a dated source re-enters the answers on risks or governance, you know before the next due diligence.

Monitoring view with score trend and automatic alerts

ReputAction platform interface, with sample data about a fictitious company.

Frequently asked questions

GEO Investor Assessment for Life Sciences: the essential answers

What is the GEO Investor Assessment for Life Sciences?

The GEO Investor Assessment for life sciences is the service that analyses what generative AI engines tell analysts, funds and counterparties about the pipeline, governance and risks of a company in the industry — before the data room — and how to correct the sources that form that first judgement.

How does the analysis work?

We ask several AI models (ChatGPT, Gemini, Perplexity, Claude, Copilot) the real questions your audience asks, identify the sources that shape the answers, with verified URLs, and deliver a GEO Score from A to F, a SWOT, reputational risks and an action plan per channel. The demo audit is ready in 48 hours.

Do AI engines also talk about pipelines and clinical data?

Yes: they repeat what they find in public sources (registries, trade press, analyses). If the updated pipeline is not published in a readable form, the old data stays in the answers. The assessment shows what those evaluating you hear.

Does AI read clinical registries?

Yes, and considers them authoritative. If the data in the registries and on the website do not match, AI reports the most widespread version, often the old one.

Is it needed before an extraordinary transaction?

That is the typical moment: primary-source interventions take effect in 4-8 weeks, press ones in 2-3 months. Monthly monitoring covers the negotiation period.

Who carries out the actions in the plan?

Your team, or us: every action in the report is operational (updating sources, making pages and listings readable by AI, looking after reviews and Wikipedia) and we can carry it out directly, or work alongside whoever already runs your channels.

How do I measure results (ROI)?

Through monitoring: periodic runs of the same questions on the same AI engines, GEO Score over time and a before/after comparison for each intervention. You see how far your positioning has moved against the investment, and an alert warns you if a negative narrative emerges.

How do we start, and what does it cost?

You start with a free demo audit, presented on a call within 48 hours: real AI answers about your brand and an indicative GEO Score. The full GEO Assessment starts from €5,000 for one audience and one country, with the baseline actions carried out by us and the 90-day re-analysis; the GEO Program, for serial content, PR, communities and monitoring, is quoted on the plan. Details are on the Pricing page.

The same assessment, for your industry

Not in life sciences? The same assessment exists in a standard version, for every industry.

Cross-industry version →

The next step

Start with the free 48-hour audit; then the GEO Assessment, from €5,000, with the baseline actions carried out by us and the 90-day re-analysis; the GEO Program for everything else.

Pricing and what is included →

Free audit in 48 hours

Want to see what AI says about you? We show you in 48 hours.

A free demo audit, no commitment: real AI answers about your brand and an indicative GEO Score, presented on a call.

No newsletter: we only contact you to reply.